The validity of explicit indicators of prescribing appropriateness

被引:16
|
作者
Tully, MP [1 ]
Cantrill, JA [1 ]
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England
关键词
appropriateness; indicators; prescribing; validity assessment;
D O I
10.1093/intqhc/mzi084
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective. To assess, from the perspective of UK hospital doctors, the content validity and operational validity of a set of 14 previously developed explicit indicators of the appropriateness of long-term prescribing started during a hospital admission. Method. A combination of data extraction from medical records and qualitative interviews with a maximum variability sample of hospital doctors. Participants. The indicators were applied to 132 new prescriptions, intended for long-term use, prescribed for 61 patients; 36 doctors, of various grades, were purposively selected for interview. Results. Appropriate prescribing was viewed as prescribing that was indicated, necessary, evidence based (using a broad meaning of 'evidence') and of acceptable cost and risk-benefit ratio. These concepts applied to individual drugs for individual patients, rather than at a more general, public health level. Where drugs had failed an indicator, rationales were explored. Often, it was missing data in the medical notes that had resulted in the drug failing the indicator. Conclusions. The 14 indicators were considered to have content validity, reflecting all aspects of appropriate prescribing discussed by the doctors. Their operational validity was less clear-cut, due to the lack of necessary data in the medical notes. This has implications for the use of explicit indicators for assessing prescribing appropriateness, as these hospital doctors did not consider that the data required for objective, systematic assessment of prescribing would ever be recorded in hospital medical notes.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 50 条
  • [1] Development and Face Validity of Explicit indicators of Appropriateness of Long Term Prescribing
    Mary P. Tully
    Najma Javed
    Judith A. Cantrill
    Pharmacy World and Science, 2005, 27 : 407 - 413
  • [2] Development and face validity of explicit indicators of appropriateness of long term prescribing
    Tully, MP
    Javed, N
    Cantrill, JA
    PHARMACY WORLD & SCIENCE, 2005, 27 (05): : 407 - 413
  • [3] Inter-rater Reliability of Explicit Indicators of Prescribing Appropriateness
    Mary P. Tully
    Judith A. Cantrill
    Pharmacy World and Science, 2005, 27 : 311 - 315
  • [4] Inter-rater reliability of explicit indicators of prescribing appropriateness
    Tully, MP
    Cantrill, JA
    PHARMACY WORLD & SCIENCE, 2005, 27 (04): : 311 - 315
  • [5] Indicators of the appropriateness of long term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability
    Cantrill, JA
    Sibbald, B
    Buetow, S
    QUALITY IN HEALTH CARE, 1998, 7 (03): : 130 - 135
  • [6] Indicators for assessing appropriateness of prescribing for elderly hospital inpatients: A pilot study
    Elliott, RA
    Woodward, MC
    Oborne, CA
    AUSTRALASIAN JOURNAL ON AGEING, 2000, 19 (01): : 59 - 59
  • [7] CONCURRENT VALIDITY OF INDICATORS OF PRESCRIBING QUALITY IN OLDER PEOPLE
    Wallerstedt, S. M.
    Belfrage, B.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E102 - E102
  • [8] Development of Prescribing Safety Indicators for General Practitioners Using RAND Appropriateness Methods
    Avery, Anthony J.
    Campbell, Stephen M.
    Dex, Grant
    Mulvaney, Caroline
    Serumaga, Brian
    Spencer, Rachel
    Lester, Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S202 - S202
  • [9] Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method
    Avery, Anthony J.
    Dex, Grant M.
    Mulvaney, Caroline
    Serumaga, Brian
    Spencer, Rachel
    Lester, Helen E.
    Campbell, Stephen M.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (589): : e526 - e536
  • [10] Validity of performance indicators for assessing prescribing quality: the case of asthma
    Lisa G. Pont
    Petra Denig
    Thys van der Molen
    Willem Jan van der Veen
    Flora M. Haaijer-Ruskamp
    European Journal of Clinical Pharmacology, 2004, 59 : 833 - 840